News | Nuclear Imaging | June 01, 2016

PET Helps Measure Awareness of Brain-Injured Patients

Scientists use radiolabeled glucose to find connection between consciousness and energy turnover capabilities

FDG-PET, brain injured patients, awareness, Current Biology study

This figure shows brain glucose metabolism as evidenced by positron emission tomography with [18F]-fluorodeoxyglucose (PET-FDG) at rest in patients with chronic disorders of consciousness (vegetative state and minimally conscious patients) and fully conscious control subjects. Please notice the dramatic drop in brain glucose metabolism from full consciousness to the minimal conscious and persistent vegetative states. Image courtesy of Stender et al.

June 1, 2016 — Researchers have new evidence that readily obtainable measures of the amount of glucose (sugar) consumed by the brain can directly predict a person's current level of awareness, or the likelihood that they will recover awareness within a year of a severe brain injury. The study was reported in the Cell Press journal Current Biology on May 26.

The precise diagnosis and prognosis of recovery of consciousness of patients after a severe brain injury is a challenging clinical task, as some brain-injured patients retain certain levels of awareness despite appearing fully unresponsive.

"In nearly all cases, whole-brain energy turnover directly predicted either the current level of awareness or its subsequent recovery," said Ron Kupers of the University of Copenhagen and Yale University. "In short, our findings indicate that there is a minimal energetic requirement for sustained consciousness to arise after brain injury."

In the new study, Kupers, together with Johan Stender and colleagues from the University of Copenhagen in Denmark and the University of Liège in Belgium, aimed to develop more reliable diagnostic markers for the assessment of current and future levels of consciousness to complement routine bedside clinical examinations. To this end, they quantified and mapped cerebral glucose metabolism in 131 brain-injured patients, all of whom were suffering from either full or partial loss of consciousness.

The researchers measured glucose metabolism using FDG-PET (positron emission tomography), a well-known imaging technique in which glucose labeled with a radioactive tracer molecule is injected into the bloodstream. The labeled glucose makes it possible to capture and map glucose uptake in any organ of interest — in this case, the brain.

Their results showed that the patients' individual levels of behavioral responsiveness were strongly linked to their overall cerebral energy turnover. In fact, patients with glucose metabolism below a well-defined threshold of 42 percent of normal cortical activity appeared to be fully unconscious and did not recover consciousness at one-year follow-up. In contrast, nearly all patients with brain metabolic activity above this energetic threshold either showed signs of awareness at the initial examination or had recovered responsiveness a year later.

Overall, the cerebral metabolic rate accounted for the current level, or imminent return, of awareness in 94 percent of patients.

"The discovery of a clear metabolic boundary between the conscious and unconscious states could imply that the brain undergoes a fundamental state change at a certain level of energy turnover, in a sense that consciousness 'ignites' as brain activity reaches a certain threshold," Stender said. "We were not able to test this hypothesis directly, but it provides a very interesting direction for future research."

"The take-home message [for now] is that consciousness is a highly energy-demanding process, involving the brain at large," Kupers said. "This fundamental physiological trait can help clinicians determine the potential for recovery of awareness in patients suffering from severe brain injuries of any kind."

The researchers said it will be important to verify the findings in an independent patient population. They also hope to explore how brain metabolism changes over time in brain-injured patients.

The study was supported financially by the University of Copenhagen, the Belgian Fund for Scientific Research, the James S. McDonnell Foundation, the Belgian American Educational Foundation, the Wallonie-Bruxelles International, the European Commission, the European Space Agency, the Wallonia- Brussels Federation Concerted Research Action, and the Belgian interuniversity attraction pole.

For more information: www.cell.com/current-biology

Related Content

Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...